Recent data indicates retatrutide peptide that retatrutide, a novel medication, could represent a significant improvement in size management. This drug combines the effects of a GLP-1 receptor and a GIP receptor , potentially offering a greater outcome than current therapies . Clinical research have revealed encouraging outcomes, including substant